Peripheral arterial disease (PAD) with focus on intermittent claudication, and results of invasive treatment on both intermittent claudication and critical limb ischemia – with outcome focus on HRQoL. One study cohort with IC, randomized between invasive treatment or best medical treatment (BMT) alone has now 1 year follow up data (showing superior results for invasive treatment) presented in an scientific paper, and is about to be followed for both 2 and 5 years. Health economics in this cohort is beeing calculated to evaluate the cost effectiveness of the treatment. Another studycohort investigating the impact of CWP on HRQoL in PAD patients has presented 1 year data showing improvment of HRQoL even in patients with CWP, this cohort will soon be investigated in a longer follow-up. 2D perfusion is a new method for evaluating the perfusion in the foot before and after invasive treatment in patients with CLI, we are running a pilot study on this now. PAE is a new method for treatment of bening prostae hyperplasia (BPH) with minimal invasive endovascular methods, we are planning a prospective study on this method compared to open surgery